{
    "2020-03-26": [
        [
            {
                "time": "2023-10-01",
                "original_text": "How Bristol Myers' New MS Drug Has A Leg-Up On A Rival From Novartis",
                "features": {
                    "keywords": [
                        "Bristol Myers",
                        "MS Drug",
                        "Novartis",
                        "Leg-Up"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "ROSEN, A HIGHLY RANKED FIRM, Continues to Investigate Securities Claims Against Novartis AG â€“ NVS",
                "features": {
                    "keywords": [
                        "Rosen",
                        "Securities Claims",
                        "Novartis AG"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "legal",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Novartis works with life sciences companies to fight Covid-19",
                "features": {
                    "keywords": [
                        "Novartis",
                        "life sciences",
                        "Covid-19"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}